Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...

Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...

Drs Kathryn J. Ruddy and Narjust Florez discuss fertility, pregnancy, sexual health, delays in diagnosis, and the financial burden of young-onset cancer survivorship.

Researchers explore glioblastoma's genetic complexity using innovative spatial profiling, aiming to enhance treatment ...

An item in Republicans’ sweeping policy and tax bill intended to block Medicaid dollars from flowing to Planned Parenthood, the nation’s biggest abortion provider, is also hitting a major medical ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

Understanding actionable mutations and educating patients on the safety profiles of targeted therapies are essential for the ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...

Planned Parenthood isn't the only abortion provider that stands to lose Medicaid payments under a budget plan signed by ...

For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer ...

The response rate to Amtagvi was higher in patients who had received two or fewer therapies than in those with more heavily ...